We aimed to evaluate fracture fixation for patients with a lateral compression type-1 pelvic fracture. However, fewer older patients with the fracture were identified than expected and Covid restrictions made it difficult to discuss the study with patients and families. We were therefore unable to recruit sufficient people into the study so it closed early.
Lateral compression type-1, a specific type of pelvic fracture, can heal without surgery; patients are offered pain relief and encouraged to move as much as they can after the injury. These fractures can be painful, and some people are not able to get up and walk for weeks. Such fractures can cause health problems like chest or urinary tract infections, pressure sores and blood clots. Pelvic surgeons think patients with this fracture may benefit from surgery with an internal fixation device (a bar and screws) to stabilise the pelvis.
We aimed to find out which treatment is better for patients and better value for money for the NHS by doing a randomised controlled trial. This required 600 people aged over 60, in hospital with a pelvic fracture and having difficulty walking to take part. Three hundred would receive surgery and 300 would receive non-surgical treatment. Over 6 months, participants would complete questionnaires, a walking assessment and have X-rays to check healing. The trial had a 12-month run-in period to see if enough people would take part.
The trial closed early as we were unable to recruit sufficient people into the study. Fewer older patients with pelvic fractures were identified than expected, 51% were able to walk after a few days and therefore were not eligible to be included in the study. Of the remaining patients, 13.6% were eligible and 30.6% of those consented to take part. Restrictions on visitors during the coronavirus disease 2019 pandemic made it difficult to discuss the study with patients’ families and fewer patients were admitted to hospital where the study was taking place. Our research question could not be answered by this study at the present time.
Privacy Notice: How we use your research data
Funder
National Institute for Health Research Health Technology Assessment Programme (16/167/57)
Sponsor
Barts Health NHS Trust
ISRCTN registration
This trial is registered as ISRCTN16478561
IRAS project number
255609
Ethics Committee & Reference Number
London – Harrow REC (Ref: 19/LO/0555)
Scotland A REC (REF 21/SS/0002)
Start Date
01.10.2018
End date
31.03.2023